Hossein, Shabnam
Cooper, Jessica A.
DeVries, Brittany A. M.
Nuutinen, Makiah R.
Hahn, Emma C.
Kragel, Philip A.
Treadway, Michael T. http://orcid.org/0000-0002-5913-114X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R00MH102355, R01MH108605, F32115692)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 8 June 2022
Revised: 17 March 2023
Accepted: 24 March 2023
First Online: 19 April 2023
Competing interests
: The authors report no conflicts of interest, financial or otherwise. In the past three years, MTT has served as a paid consultant to Blackthorn Therapeutics and Boehringer Ingelheim. None of these entities supported the current work, and all views expressed herein are solely those of the authors.